Search academic texts

Information × Registration Number 0201U001470, 0198U005181 , R & D reports Title Research and introduction in clinical practice Blasten, an immunomodulator, and antitumor vaccine, development of technology of reception of the ready medicinal forms of Lactoflor, a probiotic immunoprotector for increase effectiveness of the combined therapy of malignant diseases popup.stage_title Head Mosiyinko V. S., Registration Date 07-02-2001 Organization R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology popup.description2 The II phase of clinical tests of Blasten, an immunomodulator of domestic manufacture is carried out at the combined treatment of malignacies and other diseases. Blasten is authorized by Farmacological Commitee of Health Ministry of Ukraine for in ustrial release and wide technical application. Preclinical tests of Lactoflor are carried out according to the requirements Farmacological Commitee of Health Ministry of Ukraine, where the pharmacological properties of substance and its harmlessness and its biochemical activity were studied. The autovaccine, made on the basis of malignant cells of the patient and products of vital activity of Bac.mesentericus AB-56 is investigated in experiment and clinical tests. Product Description popup.authors popup.nrat_date 2020-04-02 Close